Last Posted: Jul 26, 2018
- PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
Sawa Kenji et al. Lung cancer (Amsterdam, Netherlands) 2017 Oct 11296-101 - Precision medicine in COPD exacerbations.
Agusti Alvar et al. The Lancet. Respiratory medicine 2018 Jul - Advances in managing COPD related to α 1 -antitrypsin deficiency, an under-recognized genetic disorder.
Craig Timothy J et al. Allergy 2018 Jul - Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
Greulich Timm et al. COPD 2017 Mar 14(sup1) S8-S11 - Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi Franck F et al. Respiratory research 2017 May 18(1) 105 - Clinical and molecular markers in COPD.
Gonçalves I et al. Pulmonology 2018 Jun - Personalized medicine for chronic, complex diseases: chronic obstructive pulmonary disease as an example.
Radder Josiah E et al. Personalized medicine 2014 Sep 11(7) 669-679 - Living With COPD
- New Ads From Former Smokers
CDC Tips Campaign, 2018 - Prioritizing complex disease risk genes by integrating multiple data.
Guo Shanshan et al. Genomics 2018 Apr
.png)
No hay comentarios:
Publicar un comentario